| Year |
Citation |
Score |
| 2010 |
Ma G, Bavadekar SA, Schaneberg BT, Khan IA, Feller DR. Effects of synephrine and beta-phenethylamine on human alpha-adrenoceptor subtypes. Planta Medica. 76: 981-6. PMID 20217639 DOI: 10.1055/S-0029-1240884 |
0.82 |
|
| 2010 |
Zheng W, Lei L, Lalchandani S, Sun G, Feller DR, Miller DD. ChemInform Abstract: Yohimbine Dimers Exhibiting Binding Selectivities for Human α2a- versus α2b-Adrenergic Receptors Cheminform. 31: no-no. DOI: 10.1002/chin.200027210 |
0.794 |
|
| 2008 |
Bavadekar SA, Hong SS, Lee SI, Miller DD, Feller DR. Bioisosteric phentolamine analogs as selective human alpha(2)- versus alpha(1)-adrenoceptor ligands. European Journal of Pharmacology. 590: 53-60. PMID 18589415 DOI: 10.1016/J.Ejphar.2008.05.027 |
0.828 |
|
| 2007 |
Ma G, Bavadekar SA, Davis YM, Lalchandani SG, Nagmani R, Schaneberg BT, Khan IA, Feller DR. Pharmacological effects of ephedrine alkaloids on human alpha(1)- and alpha(2)-adrenergic receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 322: 214-21. PMID 17405867 DOI: 10.1124/Jpet.107.120709 |
0.785 |
|
| 2006 |
Bavadekar SA, Ma G, Mustafa SM, Moore BM, Miller DD, Feller DR. Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands. The Journal of Pharmacology and Experimental Therapeutics. 319: 739-48. PMID 16873606 DOI: 10.1124/Jpet.106.105981 |
0.849 |
|
| 2006 |
Nikulin VI, Rakov IM, De Los Angeles JE, Mehta RC, Boyd LY, Feller DR, Miller DD. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline-6,7-diols as novel affinity and photoaffinity probes for beta-adrenoceptor subtypes. Bioorganic & Medicinal Chemistry. 14: 1684-97. PMID 16431119 DOI: 10.1016/J.Bmc.2005.12.027 |
0.331 |
|
| 2006 |
Hong S, Bavadekar SA, Lee S, Patil PN, Lalchandani SG, Feller DR, Miller DD. Bioisosteric Phentolamine Analogues as Potent α-Adrenergic Antagonists. Cheminform. 37. DOI: 10.1002/chin.200604036 |
0.724 |
|
| 2005 |
Hong SS, Bavadekar SA, Lee SI, Patil PN, Lalchandani SG, Feller DR, Miller DD. Bioisosteric phentolamine analogs as potent alpha-adrenergic antagonists. Bioorganic & Medicinal Chemistry Letters. 15: 4691-5. PMID 16153828 DOI: 10.1016/J.Bmcl.2005.07.083 |
0.788 |
|
| 2005 |
Mustafa SM, Bavadekar SA, Ma G, Moore BM, Feller DR, Miller DD. Synthesis and biological studies of yohimbine derivatives on human alpha2C-adrenergic receptors. Bioorganic & Medicinal Chemistry Letters. 15: 2758-60. PMID 15911252 DOI: 10.1016/J.Bmcl.2005.03.116 |
0.834 |
|
| 2005 |
Rimando AM, Nagmani R, Feller DR, Yokoyama W. Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. Journal of Agricultural and Food Chemistry. 53: 3403-7. PMID 15853379 DOI: 10.1021/Jf0580364 |
0.405 |
|
| 2004 |
Lalchandani SG, Zhang X, Hong SS, Liggett SB, Li W, Moore BM, Miller DD, Feller DR. Medetomidine analogs as selective agonists for the human alpha2-adrenoceptors. Biochemical Pharmacology. 67: 87-96. PMID 14667931 DOI: 10.1016/J.Bcp.2003.08.043 |
0.832 |
|
| 2003 |
Nagmani R, Pasco DS, Salas RD, Feller DR. Evaluation of beta-adrenergic receptor subtypes in the human prostate cancer cell line-LNCaP. Biochemical Pharmacology. 65: 1489-94. PMID 12732361 DOI: 10.1016/S0006-2952(03)00105-9 |
0.431 |
|
| 2002 |
Lalchandani SG, Lei L, Zheng W, Suni MM, Moore BM, Liggett SB, Miller DD, Feller DR. Yohimbine dimers exhibiting selectivity for the human alpha 2C-adrenoceptor subtype. The Journal of Pharmacology and Experimental Therapeutics. 303: 979-84. PMID 12438517 DOI: 10.1124/Jpet.102.039057 |
0.831 |
|
| 2002 |
Jaradat MS, Noonan DJ, Wu B, Avery MA, Feller DR, Jardat MS. Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists. Planta Medica. 68: 667-71. PMID 12221584 DOI: 10.1055/S-2002-33785 |
0.771 |
|
| 2002 |
Saha SL, Roche VF, Pendola K, Kearley M, Lei L, Romstedt KJ, Herdman M, Shams G, Kaisare V, Feller DR. Synthesis and in vitro platelet aggregation and TP receptor binding studies on bicyclic 5,8-ethanooctahydroisoquinolines and 5,8-ethanotetrahydroisoquinolines. Bioorganic & Medicinal Chemistry. 10: 2779-93. PMID 12057668 DOI: 10.1016/S0968-0896(02)00101-3 |
0.333 |
|
| 2001 |
Jaradat MS, Wongsud B, Phornchirasilp S, Rangwala SM, Shams G, Sutton M, Romstedt KJ, Noonan DJ, Feller DR. Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin. Biochemical Pharmacology. 62: 1587-95. PMID 11755111 DOI: 10.1016/S0006-2952(01)00822-X |
0.784 |
|
| 2001 |
Konkar AA, Nikulin VI, De Los Angeles J, Hong SS, Fertel RH, Miller DD, Feller DR. Biochemical activities of trimetoquinol analogs at human beta(1)- and beta(3)-adrenergic receptors. Pharmacology. 62: 45-55. PMID 11150922 DOI: 10.1159/000056071 |
0.369 |
|
| 2001 |
Zheng W, Jing L, Patil PN, Lei L, Feller DR, Miller DD. 4-(5-isothiocyanato-1,2,3,4-tetrahydro-1-naphthyl)-1H-imidazole: An imidazole-type affinity label for the α1-adrenergic receptor Medicinal Chemistry Research. 10: 318-327. |
0.358 |
|
| 2000 |
Zheng W, Lei L, Lalchandani S, Sun G, Feller DR, Miller DD. Yohimbine dimers exhibiting binding selectivities for human alpha2a- versus alpha2b-adrenergic receptors. Bioorganic & Medicinal Chemistry Letters. 10: 627-30. PMID 10762040 DOI: 10.1016/S0960-894X(00)00068-8 |
0.806 |
|
| 2000 |
He Y, Nikulin VI, Vansal SS, Feller DR, Miller DD. Synthesis and human beta-adrenoceptor activity of 1-(3,5-diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol derivatives in vitro. Journal of Medicinal Chemistry. 43: 591-8. PMID 10691685 DOI: 10.1021/jm990463j |
0.311 |
|
| 2000 |
Mehta RC, Salazar-Bookaman MM, Fertel RH, De Los Angeles J, Nikulin VI, Fraundorfer PF, Miller DD, Feller DR. Biochemical and functional characterization of 1-benzyl substituted trimetoquinol affinity analogs on rat and human beta-adrenoceptors. Biochemical Pharmacology. 59: 517-29. PMID 10660118 DOI: 10.1016/S0006-2952(99)00376-7 |
0.408 |
|
| 1999 |
Vansal SS, Feller DR. Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochemical Pharmacology. 58: 807-10. PMID 10449190 DOI: 10.1016/S0006-2952(99)00152-5 |
0.417 |
|
| 1999 |
Vansal SS, Feller DR. An efficient cyclic AMP assay for the functional evaluation of beta-adrenergic receptor ligands. Journal of Receptor and Signal Transduction Research. 19: 853-63. PMID 10349598 DOI: 10.3109/10799899909042877 |
0.4 |
|
| 1998 |
Lei L, Vaghy PL, Slavica M, De Los Angeles J, Smith B, Miller DD, Feller DR. Activation of L-type calcium channel by tolazoline derivatives: role of isothiocyanate moiety. Journal of Cardiovascular Pharmacology. 31: 721-33. PMID 9593072 DOI: 10.1097/00005344-199805000-00011 |
0.353 |
|
| 1998 |
Wongsud B, Rangwala SM, Jaradat MS, Shams G, Sutton M, Romstedt KJ, Feller DR. Stereoselective interactions of ibuprofen isomers on prostaglandin endoperoxide synthases and peroxisome proliferator-activated receptors Faseb Journal. 12: A761. |
0.773 |
|
| 1997 |
Zhang X, De Los Angeles JE, He MY, Dalton JT, Shams G, Lei L, Patil PN, Feller DR, Miller DD, Hsu FL. Medetomidine analogs as alpha 2-adrenergic ligands. 3. Synthesis and biological evaluation of a new series of medetomidine analogs and their potential binding interactions with alpha 2-adrenoceptors involving a "methyl pocket". Journal of Medicinal Chemistry. 40: 3014-24. PMID 9301663 DOI: 10.1021/Jm960642Q |
0.613 |
|
| 1997 |
Rangwala SM, O'Brien ML, Tortorella V, Longo A, Loiodice F, Noonan DJ, Feller DR. Stereoselective effects of chiral clofibric acid analogs on rat peroxisome proliferator-activated receptor alpha (rPPAR alpha) activation and peroxisomal fatty acid beta-oxidation. Chirality. 9: 37-47. PMID 9094202 DOI: 10.1002/(Sici)1520-636X(1997)9:1<37::Aid-Chir8>3.0.Co;2-D |
0.589 |
|
| 1997 |
Christoff JJ, Bradley L, Miller DD, Lei L, Rodriguez F, Fraundorfer P, Romstedt K, Shams G, Feller DR. Synthesis and evaluation of trimetoquinol derivatives: novel thromboxane A2/prostaglandin H2 antagonists with diminished beta-adrenergic agonist activity. Journal of Medicinal Chemistry. 40: 85-91. PMID 9016331 DOI: 10.1021/jm950896w |
0.332 |
|
| 1997 |
Shams G, Romstedt KJ, Lust LA, Clark MT, Miller DD, Feller DR. Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs. General Pharmacology. 28: 323-30. PMID 9013212 DOI: 10.1016/S0306-3623(96)00223-6 |
0.344 |
|
| 1996 |
Feller DR, O'Brien M, Rangwala SM, Tortorella V, Loiodice F, Noonan DJ. Structural requirements of chiral clofibric acid analogs for activation of the rat peroxisome proliferator-activated receptor alpha. Annals of the New York Academy of Sciences. 804: 713-5. PMID 8993602 DOI: 10.1111/J.1749-6632.1996.Tb18677.X |
0.432 |
|
| 1996 |
De Los Angeles JE, Nikulin VI, Shams G, Konkar AA, Mehta R, Feller DR, Miller DD. Iodinated analogs of trimetoquinol as highly potent and selective beta 2-adrenoceptor ligands. Journal of Medicinal Chemistry. 39: 3701-11. PMID 8809159 DOI: 10.1021/Jm960208O |
0.336 |
|
| 1996 |
Zhang X, Yao XT, Dalton JT, Shams G, Lei L, Patil PN, Feller DR, Hsu FL, George C, Miller DD. Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis, and biological activity of conformationally restricted naphthalene derivatives of medetomidine. Journal of Medicinal Chemistry. 39: 3001-13. PMID 8709134 DOI: 10.1021/Jm9506074 |
0.548 |
|
| 1996 |
O'Brien ML, Rangwala SM, Henry KW, Weinberger C, Crick DC, Waechter CJ, Feller DR, Noonan DJ. Convergence of three steroid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis. Carcinogenesis. 17: 185-90. PMID 8625436 DOI: 10.1093/Carcin/17.2.185 |
0.352 |
|
| 1994 |
Slavica M, Lei L, Patil PN, Kerezy A, Feller DR, Miller DD. Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta. Journal of Medicinal Chemistry. 37: 1874-81. PMID 8021927 DOI: 10.1021/Jm00038A017 |
0.462 |
|
| 1994 |
Hong SS, Romstedt KJ, Feller DR, Hsu FL, Cupps TL, Lyon RA, Miller DD. A structure-activity relationship study of benzylic modifications of 4-[1-(1-naphthyl)ethyl]-1H-imidazoles on alpha 1- and alpha 2-adrenergic receptors. Journal of Medicinal Chemistry. 37: 2328-33. PMID 7914537 DOI: 10.1021/Jm00041A011 |
0.571 |
|
| 1993 |
Romstedt KJ, Shin Y, Shams G, Doyle K, Tantishaiyakul V, Clark MT, Adejare A, Hamada A, Miller DD, Feller DR. Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta. Biochemical Pharmacology. 46: 2051-9. PMID 8267653 DOI: 10.1016/0006-2952(93)90647-F |
0.305 |
|
| 1993 |
Shin Y, Romstedt KJ, Miller DD, Feller DR. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells. The Journal of Pharmacology and Experimental Therapeutics. 267: 1017-23. PMID 7903383 |
0.373 |
|
| 1992 |
Hong SS, Romstedt KJ, Feller DR, Hsu FL, George C, Cupps TL, Lyon RA, Miller DD. Resolution and adrenergic activities of the optical isomers of 4-[1-(1-naphthyl)ethyl]-1H-imidazole. Chirality. 4: 432-8. PMID 1361151 DOI: 10.1002/Chir.530040706 |
0.496 |
|
| 1992 |
Amemiya Y, Hong SS, Venkataraman BV, Patil PN, Shams G, Romstedt K, Feller DR, Hsu FL, Miller DD. Synthesis and alpha-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogues. Journal of Medicinal Chemistry. 35: 750-5. PMID 1347319 DOI: 10.1021/Jm00082A017 |
0.53 |
|
| 1992 |
Markovich KM, Tantishaiyakul V, Hamada A, Miller DD, Romstedt KJ, Shams G, Shin Y, Fraundorfer PF, Doyle K, Feller DR. Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities. Journal of Medicinal Chemistry. 35: 466-79. PMID 1346651 DOI: 10.1021/Jm00081A007 |
0.423 |
|
| 1992 |
Esbenshade TA, Hamada A, Miller DD, Feller DR. Effects of the stereochemical orientation of phenethylamines and imidazolines on alpha-adrenergic receptor-mediated DNA synthesis in primary cultured rat hepatocytes. Chirality. 4: 279-85. PMID 1323987 DOI: 10.1002/Chir.530040504 |
0.462 |
|
| 1991 |
Shin Y, Romstedt KJ, Doyle K, Harrold MW, Gerhardt MA, Miller DD, Patil PN, Feller DR. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo Chirality. 3: 112-117. PMID 1830752 DOI: 10.1002/Chir.530030206 |
0.327 |
|
| 1991 |
Venkataraman BV, Shams G, Hamada A, Amemiya Y, Tantishaiyakul V, Hsu F, Fashempour J, Romstedt KJ, Miller DD, Feller DR. Structure-activity studies of new imidazolines on adrenoceptors of rat aorta and human platelets. Naunyn-Schmiedeberg's Archives of Pharmacology. 344: 454-63. PMID 1766472 DOI: 10.1007/BF00172586 |
0.462 |
|
| 1991 |
Shams G, Venkataraman BV, Hamada A, Miller DD, Patil PN, Feller DR. Diversity of the pharmacological actions of some tolazoline analogues in human platelets and rat aorta. European Journal of Pharmacology. 199: 315-23. PMID 1655482 DOI: 10.1016/0014-2999(91)90495-C |
0.347 |
|
| 1990 |
Shams G, Wallace LJ, Miller DD, Feller DR. Effects of thromboxane a2 on thoracic aorta of young and old rats: Use of selective thromboxane receptor antagonists Pharmacology. 40: 27-32. PMID 2139513 DOI: 10.1159/000138635 |
0.324 |
|
| 1990 |
Feller DR, Shams GS, Venkataraman BV, Romstedt KJ, Fashempour JT, Tantishaiyakul V, Miller DD, Patil PN. Alpha andrenergic activities of aromatic ring iodinated analogues of catecholimidazoline in blood vessels and platelets European Journal of Pharmacology. 183: 993. DOI: 10.1016/0014-2999(90)92838-A |
0.452 |
|
| 1990 |
Feller D, Shams G, Venkataraman B, Romstedt K, Fashempour J, Tantishaiyakul V, Miller D, Patil P. Alpha adrenergic activities of aromatic ring iodinated analogues of catecholimidazoline in blood vessels and platelets European Journal of Pharmacology. 183: 993. DOI: 10.1016/0014-2999(90)92838-A |
0.372 |
|
| 1988 |
Harrold MW, Grajzl B, Shin Y, Romstedt KJ, Feller DR, Miller DD. Synthesis and thromboxane A2 antagonist activity of N-benzyltrimetoquinol analogues Journal of Medicinal Chemistry. 31: 1506-1512. PMID 3397988 DOI: 10.1021/Jm00403A006 |
0.32 |
|
| 1988 |
Chang-Ho A, Romstedt KJ, Wallace LJ, Miller DD, Feller DR. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade Biochemical Pharmacology. 37: 3023-3033. PMID 3134894 DOI: 10.1016/0006-2952(88)90292-4 |
0.314 |
|
| 1981 |
Sober DJ, Chang J, Fowble JW, Mukhopadhyay A, Feller DR, Miller DD, Fairchild EH. Selective and potent beta 2-adrenoceptor agents within the tetrahydroisoquinoline class: effect of methyl substitution at the benzylic carbon of the 1-(3,4,5-trimethoxybenzyl) group of trimetoquinol. Journal of Medicinal Chemistry. 24: 970-4. PMID 6120236 DOI: 10.1021/Jm00140A011 |
0.307 |
|
| 1976 |
Malspeis L, Ludden TM, Bathala MS, Morrison BE, Feller DR, Reuning RH. Metabolic reduction of naltrexone II. In vitro studies using liver from guinea pig, monkey and rat. Research Communications in Chemical Pathology and Pharmacology. 14: 393-406. PMID 822483 |
0.317 |
|
| 1971 |
WITIAK DT, FELLER DR, STRATFORD ES, HACKNEY RE, NAZARETH R, WAGNER G. ChemInform Abstract: INHIBITORWIRKUNG VON ALPHA-(4-CHLORPHENOXY)-ALPHA-METHYLPROPIONSAEURE-ANALOGEN AUF DIE CHOLESTERIN-BIOSYNTH. UND DIE IN VITRO-LIPOLYSE Chemischer Informationsdienst. Organische Chemie. 2: no-no. DOI: 10.1002/chin.197150260 |
0.443 |
|
| Show low-probability matches. |